Yehuda E. Deutsch

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

Alberto J. Montero, C. Marcela Díaz‐Montero, Yehuda E. Deutsch et al. · Breast Cancer Research and Treatment · 2011 · 107 citations · Full text

Breast Oncology, Oncology, Medicine +9

Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study

Ronan T Swords, Diana J. Azzam, Hassan Al‐Ali et al. · Leukemia Research · 2017 · 58 citations · Full text

Gilteritinib clinical activity in relapsed/refractory <scp><i>FLT3</i></scp> mutated <scp>acute myeloid leukemia</scp> previously treated with <scp><i>FLT3</i></scp> inhibitors

Yazan Numan, Zaid Abdel Rahman, Justin Grenet et al. · American Journal of Hematology · 2022 · 43 citations · Full text

Stewart-Treves Syndrome: A Case Report and Review of the Literature

Roberto Berebichez‐Fridman, Yehuda E. Deutsch, Thomas Joyal et al. · Case Reports in Oncology · 2016 · 41 citations · Full text

Lymphoid Neoplasia, Vasculitis, Stewart-treves Syndrome +13

Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk <i>NPM1</i>-mutated AML

Onyee Chan, Najla H. Al Ali, Hammad Tashkandi et al. · Blood Advances · 2024 · 27 citations · Full text